-
MCC950 Sodium in Endothelial Pyroptosis Assays
2026-08-18
MCC950 sodium provides a selective way to test whether NLRP3 signaling contributes to oxidative endothelial injury. This article translates a HUVEC pyroptosis study into a practical assay strategy that separates inflammasome causality from broad antioxidant effects.
-
C34 (CAS 40592-88-9) TLR4 Inhibitor
2026-08-17
A scenario-driven guide to using C34 (CAS 40592-88-9) TLR4 Inhibitor, SKU B4925, in macrophage, enterocyte, microglial, viability, and inflammatory signaling assays. It connects product-quality data with practical controls, solution handling, dose selection, and interpretation of TLR4-dependent effects.
-
TMEM16F in Kupffer Cells Protects Against Listeria
2026-08-17
The reference study identifies Kupffer cell-expressed TMEM16F as a key determinant of host protection during Listeria monocytogenes infection, rather than assigning the main in vivo effect to T or B cells. Its experiments connect calcium-activated lipid scrambling and plasma-membrane repair with reduced Kupffer cell death, liver inflammation, and metabolic disruption.
-
NADPH Oxidase ROS Activate L-Type Ca2+ Channels
2026-08-16
This study identifies L-type voltage-gated Ca2+ channels as the principal downstream route by which NADPH oxidase-derived reactive oxygen species promote contraction in saphenous arteries from early postnatal rats. Pharmacological tests separated this mechanism from Rho-kinase, PKC, and Src-kinase signaling, providing a useful framework for developmental vascular and cell signaling pathway modulation research.
-
Substrate Stiffness and the LAMB1–FAK–MEK1/2 Axis
2026-08-15
This study shows that substrate stiffness promotes dentinogenic behavior in odontoblast-like cells through an LAMB1–FAK–MEK1/2 signaling axis. Its experimental framework connects cell morphology, mineralization, gene expression, and protein interactions, providing a mechanistic basis for designing dental biomaterials that regulate reparative dentin formation.
-
APEX2 Supports Efficient TERT Expression in hESCs
2026-08-14
The reference preprint identifies APEX2 as a DNA repair factor required for efficient TERT expression and telomerase activity in human embryonic stem cells and a melanoma model. Its transcriptomic and chromatin-binding data suggest that APEX2 may support gene expression through repair-associated interactions with repetitive DNA, particularly MIR elements within TERT intron 2.
-
C34 as a TLR4 Probe in Inflammation Research
2026-08-14
C34 is a selective TLR4 inhibitor for dissecting inflammatory signaling across macrophage, enterocyte, and neuroinflammation models. This article connects C34 pharmacology with a recent microglia study to explain how pathway-selective controls improve assay interpretation and translational relevance.
-
C34: A Precision Lens on TLR4 Inflammation
2026-08-13
C34 offers translational researchers a selective way to test whether TLR4 is a causal driver of inflammatory phenotypes. This article connects C34-based pathway validation in macrophages, enterocytes, and intestinal inflammation with emerging evidence from Taxus chinensis fruit extract and microglial neuroinflammation research.
-
SNS-032 (BMS-387032): Assay Reliability Guide
2026-08-13
A scenario-driven guide to using SNS-032 (BMS-387032), SKU A1980, in cell viability, proliferation, cytotoxicity, and mechanistic assays. It connects documented CDK potency, RNA polymerase II phosphorylation effects, formulation, and storage considerations with practical interpretation and vendor-selection decisions.
-
Gallein and GPCR Signaling: From Mechanism to Translation
2026-08-12
Gallein provides a mechanistic entry point for testing G protein βγ-dependent signaling across cancer, immune, cardiac, and emerging metabolic models. By connecting validated preclinical applications with the lactate–GPR81/FARP1 axis, this article outlines a disciplined strategy for translational assay design without overstating what is currently known.
-
Exendin-4 Workflows for Type 2 Diabetes Research
2026-08-12
Exendin-4, also known as Exenatide, supports practical assays spanning cAMP signaling, glucose-induced insulin secretion, proinsulin transcription, and translational metabolic endpoints. This guide connects reproducible peptide handling with the emerging use of stable yeast expression systems for more accessible type 2 diabetes research.
-
PDA Drug Screening: Rgs16::GFP and JQ1 Findings
2026-08-11
This study developed a concerted cell-culture and in vivo screening strategy for pancreatic ductal adenocarcinoma using Rgs16::GFP as a disease- and drug-responsive reporter. Its key finding was that combining gemcitabine, the HDAC inhibitor TSA, and active JQ1 suppressed PDA initiation and progression in preclinical models, supporting reporter-guided prioritization of combination therapies.
-
SB-3CT: MMP9, Matrix Remodeling, and Translation
2026-08-11
New work on Adamtsl3 places MMP9 at the center of perineuronal-net maintenance and cortical plasticity. This thought-leadership analysis explains how SB-3CT can serve as a selective gelatinase inhibitor for causal ECM studies while defining the boundaries between mechanistic validation, preclinical opportunity, and clinical translation.
-
NLRP3 Astrocyte Remodeling in Morphine Tolerance
2026-08-10
A 2024 Frontiers in Pharmacology study links spinal NLRP3 inflammasome activation with reactive astrocyte remodeling during morphine tolerance. By pharmacologically inhibiting NLRP3 with MCC950, the investigators delayed tolerance development and partially normalized A1- and A2-associated astrocyte markers, providing a mechanistic framework for studying neuroinflammatory contributions to opioid analgesic failure.
-
VX-765: Reading Caspase-1 Biology Correctly
2026-08-09
VX-765 enables selective investigation of caspase-1-dependent cytokine maturation and pyroptosis. This guide connects VRT-043198 pharmacology with new findings on IL-1β substrate recruitment, helping researchers design more discriminating biochemical and cellular assays.